Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-02-21

FDA Approved: CIPROFLOXACIN AND DEXAMETHASONE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for ciprofloxacin and dexamethasone from Sandoz, updating the approval status for this otic suspension product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ciprofloxacin and Dexamethasone (Ciprofloxacin and Dexamethasone)

Snippet

SUPPL AP for CIPROFLOXACIN AND DEXAMETHASONE (CIPROFLOXACIN AND DEXAMETHASONE)